GEOVAX LABS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
GEOVAX LABS, INC. (GOVX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $377.18 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-09.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2022-03-09
- GEOVAX LABS, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2021 was $377.18K, a 466.56% increase from fiscal 2020.
- GEOVAX LABS, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2020 was $66.57K, a 41.49% increase from fiscal 2019.
- GEOVAX LABS, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2019 was $47.05K, a 12.68% decline from fiscal 2018.
- GEOVAX LABS, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2018 was $53.88K, a 5.65% decline from fiscal 2017.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month as first filed |
|---|---|---|
| 2021-12-31 | $377.18K 10-K · filed 2022-03-09 | |
| 2020-12-31 | $66.57K 10-K · filed 2022-03-09 | |
| 2019-12-31 | $47.05K 10-K · filed 2021-03-23 | |
| 2018-12-31 | $53.88K 10-K · filed 2020-03-24 | |
| 2017-12-31 | $57.11K 10-K · filed 2019-03-26 | -$57.11K 10-K · filed 2018-03-23 |
| 2016-12-31 | $59.09K 10-K · filed 2019-03-26 | -$59.09K 10-K · filed 2017-03-24 |
| 2015-12-31 | -$67.90K 10-K · filed 2018-03-23 | |
| 2014-12-31 | -$26.65K 10-K · filed 2017-03-24 | |
| 2013-12-31 | -$14.05K 10-K · filed 2016-03-16 | |
| 2012-12-31 | -$21.24K 10-K · filed 2015-03-20 | |
| 2011-12-31 | -$32.67K 10-K · filed 2014-03-14 | $32.67K 10-K · filed 2013-03-18 |
| 2010-12-31 | $59.96K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |